Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial

Lancet

Volumn 353, Issue 9151, 1999, Pages 455-458

  Cleare, Anthony J ^a   Heap, Emma ^b   Malhi, Gin S ^b   Wessely, Simon ^a   O'Keane, Veronica ^b   Miell, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INSULIN;

ACNE; ADRENAL FUNCTION; ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISABILITY; FEMALE; HUMAN; INSULIN SENSITIVITY; MALE; MULTICENTER STUDY; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT;

EID: 0033528265     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)04074-4     Document Type: Article

References (28)

1. Wessely S., Chalder T., Hirsch S., Wallace P., Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health. 103:1997;1449-1455.
2. Vercoulen J., Swanink C., Fennis J., Galama J., van der Meer J., Bleijenberg G. Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatry. 60:1996;489-494.
3. David A.S. Postviral fatigue syndrome and psychiatry. Brit Med Bull. 47:1991;966-988.
4. Wearden A., Morriss R., Mullis R.et al. A double-blind, placebo controlled treatment trial of fluoxetine and a graded exercise programme for chronic fatigue syndrome. Br J Psychiatry. 172:1998;485-490.
5. Vercoulen J., Swanink C., Zitman F.et al. Fluoxetine in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled study. Lancet. 347:1996;858-861.
6. Fulcher K.Y., White P.D. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 14:1997;1647-1652.
7. Deale A., Chalder T., Marks I., Wessely S. A randomised controlled trial of cognitive behaviour versus relaxation therapy for chronic fatigue syndrome. Am J Psychiatry. 154:1997;408-414.
8. Sharpe M., Hawton K., Simkin S.et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. BMJ. 312:1996;22-26.
9. Demitrack M., Dale J., Straus S.et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 73:1991;1224-1234.
10. Cleare A.J., Bearn J., Allain T.et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord. 35:1995;283-289.
11. Dinan T.G. Glucocorticoids and the genesis of depressive illness: a psychobiological model. Br J Psychiatry. 164:1994;365-371.
12. Scott L.V., Dinan T.G. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord. 47:1998;49-54.
13. Leese G., Chattington P., Fraser W., Vora J., Edwards R., Williams G. Short-term night-shift working mimics the pituitary-adrenocortical dysfunction of chronic fatigue syndrome. J Clin Endocrinol Metab. 81:1996;1867-1870.
14. Sharpe M., Wessely S. A mind-body approach to functional somatic symptoms - the example of chronic fatigue. Watkins A. The physician's handbook of mind-body medicine. 1997;169-186 Churchill Livingstone, Edinburgh.
15. Sharpe M., Archard L., Banatvala J.et al. Chronic fatigue syndrome: guidelines for research. J R Soc Med. 84:1991;118-121.
16. Fukuda K., Straus S., Hickie I., Sharpe M., Dobbins J., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 121:1994;953-959.
17. Tanaka H., Perez M.S., Powell M.et al. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. J Clin Endocrinol Metab. 82:1997;1440-1446.
18. Sharpe M., Chalder T., Palmer I., Wessely S. Chronic fatigue syndrome: a practical guide to assessment and management. Gen Hosp Psychiatry. 19:1997;185-199.
19. Besser M., Trainer P. The Bart's endocrine protocols. 1995;Churchill Livingstone, Oxford.
20. Chalder T., Berelowitz G., Pawlikowska T.et al. Development of a fatigue scale. J Psychosom Res. 37:1993;147-153.
21. Pawlikowska T., Chalder T., Hirsch S., Wallace P., Wright D., Wessely S. A population based study of fatigue and psychological distress. BMJ. 308:1994;743-746.
22. Guy W. ECDEU assessment manual for psychopharmacology, rev. DHEW Publication No. (ABM). Washington DC: US Government Printing Office, 1976: 76-338.
23. Wittenborn J., Buhler R. Somatic discomforts among depressed women. Arch Gen Psychiatry. 36:1979;465-471.
24. Howlett T.A. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol Oxf. 46:1997;263-268.
25. Wilson A., Hickie I., Lloyd A.et al. Longitudinal study of the outcome of chronic fatigue syndrome. BMJ. 308:1994;756-760.
26. McKenzie R., O'Fallon A., Dale J.et al. Low-dose hydrocortisone treatment of chronic fatigue syndrome: results of a placebo controlled study of its efficacy and safety. JAMA. 280:1998;1061-1066.
27. Barron J.L., Noakes T.D., Levy W., Smith C., Millar R.P. Hypothalamic dysfunction in overtrained athletes. J Clin Endocrinol Metab. 60:1985;803-806.
28. Lehmann M., Gastmann U., Petersen K.et al. Training-overtraining: performance, and hormone levels, after a defined increase in training volume versus intensity in experienced middle- and long-distance runners. Br J Sports Med. 26:1992;233-242.